Document is current
Any future updates will be listed below
-
Authors
Afolabi, Muhammed O.
Sow, Doudou
Agbla, Schadrac C.
Fall, El Hadji Babacar
Sall, Fatimata Bintou
Seck, Amadou
Manga, Isaac Akhénaton
Mbaye, Ibrahima Marietou
Loum, Mor Absa
Camara, Baba
Niang, Diatou
Gueye, Babacar
Sene, Doudou
Kane, Ndéye M’backé
Diop, Boubacar
Diouf, Awa
Gaye, Ndéye Aida
Diouf, Marie Pierre
Lo, Aminata Colle
Greenwood, Brian
Ndiaye, Jean Louis A.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05354258 at ClinicalTrials.govDocuments that mention this clinical trial
Feasibility and safety of integrating mass drug administration for helminth control with seasonal malaria chemoprevention among Senegalese children: a randomized controlled, observer-blind trial
https://doi.org/10.1186/s12936-023-04784-z
-
Funding
Funding for this research was provided by:
UK Research and Innovation (MR/S03286X/1)
- License Information
-
More Information
Article History
Received: 6 September 2023
Accepted: 6 November 2023
First Online: 13 November 2023
Declarations
:
: Ethical approvals for the trial were obtained from the Research Ethics Committees of the London School of Hygiene & Tropical Medicine (Reference number 26770) and the Comité National d’Ethique pour la Recherche en Santé (CNERS) in Senegal (Reference number 0000111/MSAS/CNERS/SP). Written informed consent was obtained from parents and caregivers of the study children. For children aged ≥ 12 years, positive written assent was obtained in addition to the parental consent.
: This manuscript does not contain any individual person’s data in any form (including any individual details, images or videos), therefore, consent for publication from the parents and caregivers of the study children is not applicable.
: The authors declare that they have no competing interests.
